Job Title : Financial Analyst – Mergers & Acquisitions (Healthcare)
Location : Remote – Latin America Preferred
Type of Contract : Full-Time
Salary Range : Market Rates
Language Requirements : Advanced English
We are seeking a skilled Financial Analyst with expertise in Mergers & Acquisitions (M&A) and a strong background in the healthcare industry to join our growing team. You will play a key role in evaluating acquisition opportunities, performing detailed financial modeling, and providing insights that drive strategic growth. Your work will directly impact investment decisions and long-term organizational success.
Key Responsibilities
- Conduct in-depth financial analysis and valuation of potential M&A opportunities within the healthcare sector
- Develop and maintain complex financial models in Excel to support decision-making
- Perform due diligence, including analysis of financial statements, market trends, and operational performance
- Collaborate with cross-functional teams, legal advisors, and external consultants during transaction processes
- Prepare clear, concise reports and presentations for senior leadership and stakeholders
- Monitor post-acquisition performance and support integration planning and execution
- Stay current on healthcare industry trends, regulations, and competitive landscape
Must-Have Qualifications
Bachelor’s degree in Finance, Accounting, Economics, or related fieldProven experience in M&A financial analysis, preferably in healthcareAdvanced Excel skills, including complex formulas, pivot tables, and data modelingStrong understanding of valuation techniques such as DCF, precedent transactions, and comparable company analysisExcellent analytical, problem-solving, and quantitative skillsStrong written and verbal communication skills in EnglishAbility to work independently and manage multiple projects simultaneouslyPreferred Qualifications
MBA or CFA designation (or in progress)Experience with financial modeling software beyond Excel (e.g., Power BI, Tableau)Prior experience working with U.S.-based healthcare companies or investors#J-18808-Ljbffr